We’re proud to announce £1.5m Precision Medicine funding for targeted, less toxic cancer treatments.
Precision Medicine is an exciting new way to deliver cancer treatment to children. It takes into account individual variations in genes, environment and lifestyle. Precision therapies target specific changes in individual patients’ tumour DNA, allowing for more effective treatments while reducing toxic side effects.
Bringing Precision Medicine to young cancer patients in the UK
This treatment approach to young cancer patients has been applied in parts of the USA and Europe with some success. But, until now, efforts in the UK have been somewhat ad hoc – largely due to lack of development funding in the NHS. We want to drive forward the implementation of Precision Medicine for young cancer patients in the UK.